SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4urn'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1AJ6_A_NOVA1_1
(GYRASE)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		7 / 9 ASN A  49
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
THR A 168
 NOV  A2000 (-3.8A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-3.9A)
 0.66A 1aj6A-4urnA:
29.1		 1aj6A-4urnA:
52.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JDV_E_ADNE4260_1
(5'-METHYLTHIOADENOSI
NE PHOSPHORYLASE)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		5 / 12 ARG A 193
GLY A  38
GLU A 192
SER A  33
ASP A  35
 None
 1.44A 1jdvE-4urnA:
undetectable
1jdvF-4urnA:
undetectable		 1jdvE-4urnA:
23.13
1jdvF-4urnA:
23.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1KIJ_A_NOVA400_1
(DNA GYRASE SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		8 / 12 ASP A  52
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
ARG A 138
THR A 168
 NOV  A2000 (-4.6A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
NOV  A2000 (-3.9A)
 0.89A 1kijA-4urnA:
27.9		 1kijA-4urnA:
32.07
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1KIJ_B_NOVB444_1
(DNA GYRASE SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		9 / 12 ASN A  49
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
ALA A 122
ARG A 138
THR A 168
 NOV  A2000 (-3.8A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 ( 4.6A)
NOV  A2000 (-2.9A)
NOV  A2000 (-3.9A)
 0.78A 1kijB-4urnA:
28.2		 1kijB-4urnA:
32.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1PK7_A_ADNA1245_1
(PURINE NUCLEOSIDE
PHOSPHORYLASE)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		5 / 9 ARG A 193
GLY A  38
GLU A 192
SER A  33
ASP A  35
 None
 1.47A 1pk7A-4urnA:
undetectable		 1pk7A-4urnA:
22.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1S14_A_NOVA1300_1
(TOPOISOMERASE IV
SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		11 / 12 ASN A  49
SER A  50
ASP A  52
GLU A  53
ASP A  76
ARG A  79
MET A  81
PRO A  82
ILE A  96
ARG A 138
THR A 168
 NOV  A2000 (-3.8A)
NOV  A2000 ( 3.7A)
NOV  A2000 (-4.6A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-3.8A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
NOV  A2000 (-3.9A)
 0.79A 1s14A-4urnA:
24.9		 1s14A-4urnA:
38.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1S14_B_NOVB2300_1
(TOPOISOMERASE IV
SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		10 / 12 ASN A  49
SER A  50
ASP A  52
GLU A  53
ASP A  76
ARG A  79
MET A  81
PRO A  82
ILE A  96
ARG A 138
 NOV  A2000 (-3.8A)
NOV  A2000 ( 3.7A)
NOV  A2000 (-4.6A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-3.8A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
 0.92A 1s14B-4urnA:
26.9		 1s14B-4urnA:
38.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WA2_B_SAMB1267_1
(NON-STRUCTURAL
PROTEIN 5)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		3 / 3 SER A 123
HIS A  41
ASP A  35
 None
 0.80A 2wa2B-4urnA:
undetectable		 2wa2B-4urnA:
19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BXO_A_SAMA238_1
(N,N-DIMETHYLTRANSFER
ASE)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		3 / 3 TYR A 223
GLU A 219
ASP A 210
 None
 0.78A 3bxoA-4urnA:
undetectable		 3bxoA-4urnA:
24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BXO_B_SAMB238_1
(N,N-DIMETHYLTRANSFER
ASE)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		3 / 3 TYR A 223
GLU A 219
ASP A 210
 None
 0.72A 3bxoB-4urnA:
undetectable		 3bxoB-4urnA:
24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GV1_B_BEZB303_0
(DISULFIDE
INTERCHANGE PROTEIN)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		4 / 4 LEU A  42
ALA A 127
VAL A  23
PRO A  27
 None
 1.14A 3gv1B-4urnA:
undetectable		 3gv1B-4urnA:
21.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LPS_A_NOVA901_1
(TOPOISOMERASE IV
SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		11 / 12 ASN A  49
SER A  50
ASP A  52
GLU A  53
ASP A  76
ARG A  79
MET A  81
PRO A  82
ILE A  96
ARG A 138
THR A 168
 NOV  A2000 (-3.8A)
NOV  A2000 ( 3.7A)
NOV  A2000 (-4.6A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-3.8A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
NOV  A2000 (-3.9A)
 0.69A 3lpsA-4urnA:
27.9		 3lpsA-4urnA:
30.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4G19_D_ACTD305_0
(GLUTATHIONE
TRANSFERASE GTE1)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		4 / 4 ILE A  62
LEU A 204
LYS A 205
ASN A  77
 None
 1.42A 4g19D-4urnA:
undetectable		 4g19D-4urnA:
21.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4URO_A_NOVA2000_1
(DNA GYRASE SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		8 / 12 ASN A  49
SER A  50
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
ARG A 138
 NOV  A2000 (-3.8A)
NOV  A2000 ( 3.7A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
 0.66A 4uroA-4urnA:
30.0		 4uroA-4urnA:
58.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4URO_B_NOVB2000_1
(DNA GYRASE SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		8 / 12 ASN A  49
SER A  50
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
ARG A 138
 NOV  A2000 (-3.8A)
NOV  A2000 ( 3.7A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
 0.63A 4uroB-4urnA:
30.2		 4uroB-4urnA:
58.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4URO_C_NOVC2000_1
(DNA GYRASE SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		7 / 12 ASN A  49
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
ARG A 138
 NOV  A2000 (-3.8A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
 0.65A 4uroC-4urnA:
30.5		 4uroC-4urnA:
58.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4URO_D_NOVD2000_1
(DNA GYRASE SUBUNIT B)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		9 / 12 ASN A  49
SER A  50
GLU A  53
ASP A  76
ARG A  79
PRO A  82
ILE A  96
ARG A 138
THR A 168
 NOV  A2000 (-3.8A)
NOV  A2000 ( 3.7A)
NOV  A2000 (-3.4A)
NOV  A2000 (-3.5A)
NOV  A2000 (-3.2A)
NOV  A2000 (-4.1A)
NOV  A2000 (-4.2A)
NOV  A2000 (-2.9A)
NOV  A2000 (-3.9A)
 0.62A 4uroD-4urnA:
29.9		 4uroD-4urnA:
58.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6F88_B_STRB502_1
(CYTOCHROME P450
CYP260A1)		 4urn DNA TOPOISOMERASE
IV, B SUBUNIT
(Staphylococcus
aureus) 		4 / 6 LEU A 204
LEU A 194
SER A  50
ASN A 209
 None
None
NOV  A2000 ( 3.7A)
None
 0.95A 6f88B-4urnA:
undetectable		 6f88B-4urnA:
13.78